, January 09, 2018 ) North America Extracorporeal Membrane Oxygenation Machine Market
Size is expected to grow at a 4.12% CAGR from 2016 to 2021 and it is projected that the North-America market was valued at USD 86.52 million in 2016 and is anticipated to reach USD 105.87 million by 2021.
ECMO stands for extracorporeal membrane oxygenation. The ECMO machine is similar to the heart-lung by-pass machine used in open-heart surgery. It pumps and oxygenates a patient's blood outside the body, allowing the heart and lungs to rest. When you are connected to an ECMO, blood flows through tubing to an artificial lung in the machine that adds oxygen and takes out carbon dioxide; then the blood is warmed to body temperature and pumped back into your body. There are two types of ECMO. The VA ECMO is connected to both a vein and an artery and is used when there are problems with both the heart and lungs. The VV ECMO is connected to one or more veins, usually near the heart, and is used when the problem is only in the lungs. USCF is also now using a smaller portable ECMO device that is light enough to be carried by one person and can be transported in an ambulance or helicopter, making it possible to provide ECMO relief in emergency cases.
Full report at: http://www.marketdataforecast.com/market-reports/north-america-extracorporeal-membrane-oxygenation-machine-market-4978/
The growth of the market can be credited to the rise in the number of cases of cardiovascular and respiratory diseases, the increase in the adoption of ECMO as a bridge to lung transplantation, increasing number of ECMO centers, conferences and training programs to increase awareness, and technological advancements. In addition, the increase in the geriatric population and the number of people suffering from diseases in populous countries are factors that are projected to drive the growth of the market. Moreover, surge in the adoption of unhealthy lifestyle and the subsequent development of lifestyle ailments are projected to further expand the COPD incidence rate. Identified risk factors, such as the increase in the tobacco consumption trend in both, males and females, are further supporting the growth of the market. Be that as it may, complications associated with extracorporeal membranes oxygenation machines such as bleeding, infections, and technical failures along with high cost and lack of skilled professionals is a challenge to the market.
The North America Extracorporeal Membrane Oxygenation Machine Market Segmentation on the basis of Modality and Application. On the basis of Modality, it is segmented into Veno-Arterial (VA), Veno-Venous (VV) and Arterio-Venous (AV). The veno-venous (VV) segment is expected to account for the largest share of this market segment. The arteriovenous (AV) segment is projected to grow at the highest CAGR in the coming years. On the basis of application, it is segmented into Respiratory, Cardiac and Extracorporeal Cardiopulmonary Resuscitation (ECPR). The respiratory segment accounts for the largest share of this market segment.
On the basis of geography, the market is analyzed under various regions namely U.S. and Canada. North America held the largest share of the market. The favorable reimbursement scenario, rising incidence of lung cancer, and the presence of a large number of ECMO centers in the U.S. is expected to boost the market for ECMO systems in North America.
Some of the Major North America Extracorporeal Membrane Oxygenation Machine Market Leaders are Getinge Group, Medtronic plc, LivaNova PLC, XENIOS AG, Terumo Corporation, MicroPort Scientific Corporation, NIPRO Corporation, OriGen Biomedical Inc., ALung Technologies Inc. and EUROSETS S.r.l.
About Market Data Forecast:
The publisher of this report is Market Data Forecast whose forte lies in Market research and Business Intelligence. Handling both individual and corporate clients across multiple business domains they offer syndicated/customized research to suit the client’s research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit, www.marketdataforecast.com
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases
Market Data Forecast